EU-ToxRisk Commercial Platform for New Approach Methods (NAMs) in Safety Assessment

The EU-ToxRisk Commercial Platform was launched at the EU-ToxRisk Stakeholder meeting in Egmond, Netherlands on 12 February. The founding group of partners presented on different capabilities and services in integrated testing and assessment including a tiered approach starting with the best use of current data and in silico methods, modelling, read across and in vitro testing based on NAMs. Illustrated solutions included endocrine disruptor screening, liver and kidney investigative toxicology, and neurotoxicity screening.